WROE THOMAS JR 4
4 · Sensata Technologies Holding plc · Filed Nov 4, 2020
Insider Transaction Report
Form 4
WROE THOMAS JR
DirectorChief Executive Officer
Transactions
- Sale
Ordinary Shares, par value EUR 0.01 per share
2020-11-03$45.14/sh−36,417$1,643,809→ 4,078 total - Exercise/Conversion
Stock options to Buy
2020-11-03−36,417→ 101,200 totalExercise: $35.01Exp: 2021-04-01→ Ordinary Shares, par value EUR 0.01 per share (36,417 underlying) - Sale
Ordinary Shares, par value EUR 0.01 per share
2020-11-02$45.01/sh−13,583$611,391→ 4,078 total - Exercise/Conversion
Ordinary Shares, par value EUR 0.01 per share
2020-11-02$35.01/sh+13,583$475,541→ 17,661 total - Exercise/Conversion
Ordinary Shares, par value EUR 0.01 per share
2020-11-03$35.01/sh+36,417$1,274,959→ 40,495 total - Exercise/Conversion
Stock options to Buy
2020-11-02−13,583→ 137,617 totalExercise: $35.01Exp: 2021-04-01→ Ordinary Shares, par value EUR 0.01 per share (13,583 underlying)
Holdings
- 11,749(indirect: See note below)
Ordinary Shares, par value EUR 0.01 per share
Footnotes (7)
- [F1]Includes 4,078 unvested restricted stock units that are not subject to performance conditions.
- [F2]Reflects the sale of an aggregate of 13,583 shares of common stock on November 2, 2020, at the weighted average sales price of $45.0115. The prices for these sales range from $45.00 to $45.06. The filer undertakes to provide, upon request by the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Reflects the sale of an aggregate of 36,417 shares of common stock on November 3, 2020, at the weighted average sales price of $45.1385. The prices for these sales range from $45.00 to $45.50. The filer undertakes to provide, upon request by the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]Includes 6,464 ordinary shares held indirectly by a trust established for the benefit of the reporting person's children and 5,285 ordinary shares held indirectly by a living revocable trust.
- [F5]These options were set to expire April 1, 2021.
- [F6]A portion of these options became exercisable on April 1, 2012 and a portion on December 17, 2012.
- [F7]The amount of derivative securities beneficially owned following the reported transaction represents options that are currently exercisable and are set to expire April 1, 2021.